Metolazone Tablet
Product Images NDC 0904-7521

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metolazone (NDC 0904-7521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (1e566c10 4498 4f79 8874 4cc8c4216213 1)

Chemical structure of metolazone, showing its molecular arrangement including chlorine, sulfonamide, and aromatic ring components.*

FDA Label Image

Ingenus Logo (1e566c10 4498 4f79 8874 4cc8c4216213 5)

FDA Label Image

2.5mg Carton Label (Image 01)

Metolazone 2.5 mg tablets, USP by Major Pharmaceuticals. The label shows unit dose packaging containing 100 tablets (10 x 10). It includes dosage form as oral tablets and states Rx only. Additional label information covers formulation details, storage instructions, and manufacturer address in Indianapolis, IN, USA.*

FDA Label Image

5mg Carton Label (Image 02)

Label for Metolazone 5 mg tablets, USP, oral unit dose by Major Pharmaceuticals. The label shows two sections with product name, strength, NDC 0904-7521-61, quantity of 100 tablets (10 x 10), and Rx only. Additional text includes dosage, storage instructions, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.